Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Blood Retrieve available abstracts of 250 articles: HTML format Text format

Single Articles

January 2012
1. JUNG HJ , Chen Z, Wang M, Fayad L, et al
   Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma (MCL) via manipulation of tissue transglutaminase activities.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GUILLOTON F , Caron G, Menard C, Pangault C, et al
   Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. DI SABATINO A , Biagi F, Gobbi PG, Corazza GR, et al
   How I treat enteropathy-associated T-cell lymphoma.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GUPTA P , Goldenberg DM, Rossi EA, Cardillo TM, et al
   Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. 
   RETRACTION: Xin Huang, Kushi Kushekhar, Ilja Nolte, Wierd Kooistra, Lydia Visser, Ilby Bouwman, Niels Kouprie, Rianne Veenstra, Gustaaf van Imhoff, Bianca Olver, Richard S. Houlston, Sibrand Poppema, Arjan Diepstra, Bouke Hepkema and Anke van den Berg
   Blood. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
6. KLAPPER W , Kreuz M, Kohler CW, Burkhardt B, et al
   Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CARLRING J , Szabo MJ, Dickinson R, De Leenheer E, et al
   Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and anti-tumor effects in mice.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SABBAH S , Jagne YJ, Zuo J, de Silva T, et al
   T-cell immunity to Kaposi's sarcoma-associated herpesvirus: recognition of primary effusion lymphoma with LANA-specific CD4+ T cells.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PREGNO P , Chiappella A, Bello M, Botto B, et al
   The interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LACASCE AS , Vandergrift JL, Rodriguez MA, Abel GA, et al
    Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database.
    Blood. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. GERARD L , Michot JM, Burcheri S, Fieschi C, et al
    Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.
    Blood. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CAIRNS RA , Iqbal J, Lemonnier F, Kucuk C, et al
    IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
    Blood. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
13. KRIDEL R , Meissner B, Rogic S, Boyle M, et al
    Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MEADOWS SA , Vega F, Kashishian A, Johnson D, et al
    PI3Kdelta inhibitor, GS-1101(CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. O'CALLAGHAN K , Lee L, Nguyen N, Hsieh MY, et al
    Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MOSKOWITZ CH , Matasar MJ, Zelenetz AD, Nimer SD, et al
    Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. WILKINSON ST , Vanpatten KA, Fernandez DR, Brunhoeber P, et al
    Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. GHOSH SK , Perrine SP, Williams RM, Faller DV, et al
    Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside anti-viral agents.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SJOBERG J , Halthur C, Kristinsson SY, Landgren O, et al
    Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden 1973-2009.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MA YP , van Leeuwen FE, Cooke R, Broeks A, et al
    FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. LUPOV IP , Voiles L, Han L, Schwartz A, et al
    Acquired STAT4 deficiency as a consequence of cancer chemotherapy.
    Blood. 2011;118:6097-106.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
22. MISHRA A , Porcu P
    Early CTCL diagnosis, a (miR)age no more?
    Blood. 2011;118:5717-8.
    PubMed     Text format     Related articles   
    
    
    
    
23. RAO VK , Oliveira JB
    How I treat autoimmune lymphoproliferative syndrome.
    Blood. 2011;118:5741-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. EVENS AM , Helenowski I, Ramsdale E, Nabhan C, et al
    A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ARRIBAS JA , Campos-Martin Y, Gomez-Abad C, Algara P, et al
    Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. TAYLOR GM , Raghuwanshi SK, Rowe DT, Wadowsky RM, et al
    Endoplasmic reticulum stress causes EBV lytic replication.
    Blood. 2011;118:5528-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KALAC M , Scotto L, Marchi E, Amengual J, et al
    HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.
    Blood. 2011;118:5506-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. DAGAN LN , Jiang X, Bhatt S, Cubedo E, et al
    miR-155 regulates HGAL expression and increases lymphoma cell motility.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. COZEN W , Li D, Best T, Van Den Berg DJ, et al
    A genome-wide meta-analysis of nodular sclerosis Hodgkin lymphoma identifies risk loci at 6p21.32.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. YRI OE , Torfoss D, Hungnes O, Tierens A, et al
    Rituximab blocks protective serological response to influenza A(H1N1) 2009 vaccination in lymphoma patients during or within six months after treatment.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. SPAARGAREN M
    Lymphoma spread? Target CD47-SIRPalpha!
    Blood. 2011;118:4762-4.
    PubMed     Text format     Related articles   
    
    
    
    
32. WITZIG TE , Tang H, Micallef IN, Ansell SM, et al
    Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
    Blood. 2011;118:4882-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
33. MATSUYAMA H , Suzuki HI, Nishimori H, Noguchi M, et al
    miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ALINARI L , Mahoney E, Patton J, Zhang X, et al
    FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BIEGING KT , Fish K, Bondada S, Longnecker R, et al
    A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt's lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LUCIONI M , Novara F, Fiandrino G, Riboni R, et al
    Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
    Blood. 2011;118:4591-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SCHUSTER C , Berger A, Hoelzl MA, Putz EM, et al
    The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas.
    Blood. 2011;118:4635-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CHENG S , Coffey G, Zhang XH, Shaknovich R, et al
    SYK inhibition and response prediction in diffuse large B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BERGLUND M , Enblad G, Thunberg U
    SNP rs6457327 is a predictor for overall survival in follicular lymphoma as well as survival after transformation.
    Blood. 2011;118:4489.
    PubMed     Text format     Related articles   
    
    
    
    
40. CALPE E , Codony C, Baptista MJ, Abrisqueta P, et al
    ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
    Blood. 2011;118:4401-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. HEIDER KH , Kiefer K, Zenz T, Volden M, et al
    A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies.
    Blood. 2011;118:4159-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SUZUKI R , Yamaguchi M, Izutsu K, Yamamoto G, et al
    Prospective measurement of Epstein-Barr virus DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. VAWDA A , Davis J, Vercauteren S
    Leukemic transformation of anaplastic large-cell lymphoma.
    Blood. 2011;118:3763.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
44. LEICH E , Zamo A, Horn H, Haralambieva E, et al
    MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. AHMADI M , King JW, Xue SA, Voisine C, et al
    CD3 limits the efficacy of TCR gene therapy in vivo.
    Blood. 2011;118:3528-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BONZHEIM I , Salaverria I, Haake A, Gastl G, et al
    A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma.
    Blood. 2011;118:3442-3444.
    PubMed     Text format     Related articles   
    
    
    
    
47. SOKOL L
    Fox and Blimp in NK-cell lymphoma.
    Blood. 2011;118:3192-3193.
    PubMed     Text format     Related articles   
    
    
    
    
48. KARUBE K , Nakagawa M, Tsuzuki S, Takeuchi I, et al
    Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses.
    Blood. 2011;118:3195-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. FEHNIGER TA , Larson S, Trinkaus K, Siegel MJ, et al
    A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. GOMEZ-ABAD C , Pisonero H, Blanco-Aparicio C, Roncador G, et al
    PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HUANG X , Kushekhar K, Nolte I, Kooistra W, et al
    Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. NG SB , Yan J, Huang G, Selvarajan V, et al
    Dysregulated microRNAs affect pathways and targets of biological relevance in nasal-type natural killer/T-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. BOLL B , Bredenfeld H, Gorgen H, Halbsguth T, et al
    Phase II study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SMITH SM
    sIL-2Ralpha + IL-2: fertilizer for tolerance.
    Blood. 2011;118:2645-6.
    PubMed     Text format     Related articles   
    
    
    
    
55. AHLGRIMM M , Pfreundschuh M, Kreuz M, Regitz E, et al
    Impact of Fc-gamma receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. LIM SH , Vaughan AT, Ashton-Key M, Williams EL, et al
    Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.
    Blood. 2011;118:2530-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
57. ROSSI D , Deaglio S, Dominguez-Sola D, Rasi S, et al
    Alteration of BIRC3 and multiple other NF-{kappa}B pathway genes in splenic marginal zone lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. GRIFFITHS R , Mikhael J, Gleeson M, Danese M, et al
    Addition of rituximab to chemotherapy alone as first-line therapy improves over-all survival in elderly patients with mantle cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. SAVAGE KJ , Skinnider B, Al-Mansour M, Sehn LH, et al
    Treating limited stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BOSCH R , Dieguez-Gonzalez R, Cespedes MV, Parreno M, et al
    A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. FARREN TW , Giustiniani J, Liu FT, Tsitsikas DA, et al
    Differential and tumor-specific expression of CD160 in B-cell malignancies.
    Blood. 2011;118:2174-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. RALFKIAER U , Hagedorn PH, Bangsgaard N, Lovendorf MB, et al
    Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ZAPPASODI R , Bongarzone I, Ghedini GC, Castagnoli L, et al
    Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. LAURENT C , Muller S, Do C, Al-Saati T, et al
    Distribution, function and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue imaging study.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. COLLINS IM , O'Mahony D
    Hodgkin lymphoma in the central nervous system.
    Blood. 2011;118:1721.
    PubMed     Text format     Related articles   
    
    
    
    
66. ROSSI EA , Rossi DL, Cardillo TM, Stein R, et al
    Preclinical studies on targeted delivery of multiple IFNalpha2b to HLA-DR in diverse hematologic cancers.
    Blood. 2011;118:1877-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. JONES RJ , Baladandayuthapani V, Neelapu S, Fayad LE, et al
    HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. CHRISTENSEN DJ , Chen Y, Oddo J, Matta KM, et al
    SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin's lymphoma: a predictor of aggressive disease and new treatment target.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. NIELSEN SF , Bojesen SE, Birgens HS, Nordestgaard BG, et al
    Risk of thyroid cancer, brain cancer, and non-Hodgkin's lymphoma following adult leukemia: a nationwide study.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. KEMPF W , Pfaltz K, Vermeer MH, Cozzio A, et al
    European Organization for Research and Treatment of Cancer (EORTC), International Society of Cutaneous Lymphoma (ISCL) and United States Cutaneous Lymphoma Consortium (USCLC) consensus recommendations for the treatment of primary cutaneous CD30-positi
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. CHANG ET , Canchola AJ, Cockburn M, Lu Y, et al
    Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.
    Blood. 2011;118:1591-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. EICHENAUER DA , Fuchs M, Pluetschow A, Klimm B, et al
    Phase II study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. CHAO MP , Tang C, Pachynski RK, Chin R, et al
    Extra-nodal dissemination of non-Hodgkin's lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. ELLIOTT NE , Cleveland SM, Grann V, Janik J, et al
    FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. HILCHEY SP , Rosenberg AF, Hyrien O, Secor-Socha S, et al
    Follicular lymphoma tumor infiltrating T-helper (TH) cells have the same polyfunctional potential as normal nodal TH cells despite skewed differentiation.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. VISANI G , Malerba L, Stefani PM, Capria S, et al
    BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant is safe and effective for resistant/relapsed lymphoma patients.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
77. KUPPERS R
    CCR7 & lymphotoxin in lymphoma niche.
    Blood. 2011;118:831-2.
    PubMed     Text format     Related articles   
    
    
    
    
78. HADZIDIMITRIOU A , Agathangelidis A, Darzentas N, Murray F, et al
    Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. KUPPERS R
    NPAT mutations in Hodgkin lymphoma.
    Blood. 2011;118:484-5.
    PubMed     Text format     Related articles   
    
    
    
    
80. VEERAMANI S , Wang SY, Dahle C, Blackwell S, et al
    Rituximab infusion induces NK activation in lymphoma patients with the high affinity CD16 polymorphism.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. JEGALIAN AG , Eberle FC, Pack SD, Mirvis M, et al
    Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. LAROSA F , Deconinck E, Helias P, Fontan J, et al
    Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation.
    Blood. 2011;118:476-8.
    PubMed     Text format     Related articles   
    
    
    
    
83. ARMITAGE JO
    PET scans: when and how?
    Blood. 2011;118:2-3.
    PubMed     Text format     Related articles   
    
    
    
    
84. WARSAME AA , Aasheim HC, Nustad K, Troen G, et al
    Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
85. YANG ZZ , Grote DM, Ziesmer SC, Manske MK, et al
    Soluble IL-2R{alpha} facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. GOKBUGET N , Basara N, Baurmann H, Beck J, et al
    High single drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. STEIDL C , Gascoyne RD
    The molecular pathogenesis of primary mediastinal large B cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. GUADAGNOLI M , Kimberley FC, Phan U, Cameron K, et al
    Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
    Blood. 2011;117:6856-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. REN M , Cowell JK
    Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
    Blood. 2011;117:6837-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. ROY D , Sin SH, Damania B, Dittmer DP, et al
    Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. DESJOBERT C , Renalier MH, Bergalet J, Dejean E, et al
    MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression.
    Blood. 2011;117:6627-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MICALLEF IN , Maurer MJ, Wiseman GA, Nikcevich DA, et al
    Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. BAZARBACHI A , Suarez F, Fields P, Hermine O, et al
    How I treat adult T-cell leukemia/lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. ALIZADEH AA , Gentles AJ, Alencar AJ, Liu CL, et al
    Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes reflecting tumor and microenvironment.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. BUENO MJ , Gomez de Cedron M, Gomez-Lopez G, Perez de Castro I, et al
    Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.
    Blood. 2011;117:6255-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. YAGASAKI H , Ohashi H, Ito M, Kobayashi S, et al
    A novel mechanism of transplacental cancer transmission: natural killer/T-cell lymphoma in the paratesticular region is of maternal origin.
    Blood. 2011;117:6046-7.
    PubMed     Text format     Related articles   
    
    
    
    
97. VRZALIKOVA K , Vockerodt M, Leonard S, Bell A, et al
    Down-regulation of BLIMP1alpha by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
    Blood. 2011;117:5907-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. MONTES-MORENO S , Martinez N, Sanchez-Espiridion B, Diaz Uriarte R, et al
    MicroRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
99. BHALLA S , Evens AM, Dai B, Prachand S, et al
    The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. FERRERI AJ
     How I treat primary CNS lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. FRIEDBERG JW
     Hodgkin lymphoma: answers take time!
     Blood. 2011;117:5274-6.
     PubMed     Text format     Related articles   
     
     
     
     
102. MOUTSIANAS L , Enciso-Mora V, Ma YP, Leslie S, et al
     Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. REHM A , Mensen A, Schradi K, Gerlach K, et al
     Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. BOLES NC , Lin KK, Lukov GL, Bowman TV, et al
     CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. DELABIE J , Holte H, Vose JM, Ullrich F, et al
     Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. TREON SP , Soumerai JD, Hunter ZR, Patterson CJ, et al
     Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. CAMPO E , Swerdlow SH, Harris NL, Pileri S, et al
     The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
     Blood. 2011;117:5019-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. SAARINEN S , Aavikko M, Aittomaki K, Launonen V, et al
     Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. LANOY E , Rosenberg PS, Fily F, Lascaux AS, et al
     HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. SALLES G , de Jong D, Xie W, Rosenwald A, et al
     Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.
     Blood. 2011.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
111. MUNARI F , Lonardi S, Cassatella MA, Doglioni C, et al
     Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
112. ALDUAIJ W , Ivanov A, Honeychurch J, Cheadle EJ, et al
     Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.
     Blood. 2011;117:4519-29.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. MARTINELLI P , Bonetti P, Sironi C, Pruneri G, et al
     The lymphoma-associated NPM-ALK oncogene elicits a p16INKa/pRb-dependent tumour-suppressive pathway.
     Blood. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
114. CASASNOVAS RO , Meignan M, Berriolo-Riedinger A, Bardet S, et al
     SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
115. SHAFFER DR , Savoldo B, Yi Z, Chow KK, et al
     T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies.
     Blood. 2011;117:4304-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. GOPAL AK , Guthrie KA, Rajendran J, Pagel JM, et al
     90Y-ibritumomab tiuxetan, fludarabine, and TBI based non-myeloablative allogeneic transplant conditioning for patients with persistent high-risk B-cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. KAMPER P , Ludvigsen M, Bendix K, Hamilton-Dutoit S, et al
     Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed /refractory disease in classical Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. FOSS FM , Zinzani PL, Vose JM, Gascoyne RD, et al
     Peripheral T-cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. SALAVERRIA I , Philipp C, Oschlies I, Kohler CW, et al
     Translocations activating IRF4 identify a subtype of germinal-center-derived B-cell lymphoma affecting predominantly children and young adults.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. ASSELIN BL , Devidas M, Wang C, Pullen J, et al
     Effectiveness of high dose methotrexate in T-cell lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. WANG Y , Su M, Zhou LL, Tu P, et al
     Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription.
     Blood. 2011;117:3826-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. CRAIG VJ , Cogliatti SB, Imig J, Renner C, et al
     Myc-mediated repression of microRNA-34a promotes high grade transformation of B-cell lymphoma by dysregulation of FoxP1.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
123. SABOURDY F , Selves J, Astudillo L, Laurent C, et al
     Is active acid sphingomyelinase required for the antiproliferative response to rituximab?
     Blood. 2011;117:3695-6.
     PubMed     Text format     Related articles   
     
     
     
     
124. UMINO A , Nakagawa M, Utsunomiya A, Tsukasaki K, et al
     Clonal evolution of adult T-cell leukemia/lymphoma takes place in lymph node.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. SHIRLEY CM , Chen J, Shamay M, Li H, et al
     Bortezomib induction of C/EBP{beta} mediates Epstein-Barr virus lytic activation in Burkitt's lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. ATTARBASCHI A , Mann G, Rosolen A, Williams D, et al
     Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma (ALCL).
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. GUTIERREZ-GARCIA G , Cardesa-Salzmann T, Climent F, Gonzalez-Barca E, et al
     Gene expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. ARMANIOUS H , Gelebart P, Anand M, Belch A, et al
     Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNF{alpha}/NF{kappa}B pathway.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. CHUNG JS , Shiue LH, Duvic M, Pandya A, et al
     Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface.
     Blood. 2011;117:3382-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. GIULINO L , Mathew S, Ballon G, Chadburn A, et al
     A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. WAGNER-JOHNSTON ND , Gellert L, Gocke CD, Lemas MV, et al
     Clonal immunoglobulin DNA in the plasma of patients with AIDS-lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. DOJCINOV SD , Venkataraman G, Pittaluga S, Wlodarska I, et al
     Age related EBV associated lymphoproliferative disorder - a spectrum of reactive lymphoid hyperplasia and lymphoma: the Western experience.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. EICHENAUER DA , Engert A
     One size for all in Hodgkin lymphoma?
     Blood. 2011;117:2557-8.
     PubMed     Text format     Related articles   
     
     
     
     
134. IANNITTO E , Tripodo C
     How I diagnose and treat splenic lymphomas.
     Blood. 2011;117:2585-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. BOHLIUS J , Schmidlin K, Boue F, Fatkenheuer G, et al
     HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
136. PIEKARZ RL , Frye R, Prince HM, Kirschbaum MH, et al
     Phase II trial of romidepsin in patients with peripheral T-cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. STRAUS DJ , Johnson JL, Lacasce AS, Bartlett NL, et al
     Doxorubicin, vinblastine, gemcitabine (CALGB 50203) for stage I/II non-bulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. MAZAN-MAMCZARZ K , Hagner PR, Zhang Y, Dai B, et al
     ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes.
     Blood. 2011;117:2441-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. KIESSLING MK , Oberholzer PA, Mondal C, Karpova MB, et al
     High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.
     Blood. 2011;117:2433-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. YAP DB , Chu J, Berg T, Schapira M, et al
     Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
     Blood. 2011;117:2451-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. AUKEMA SM , Siebert R, Schuuring E, van Imhoff GW, et al
     Double-hit B-cell lymphomas.
     Blood. 2011;117:2319-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. STRAKA C , Sandherr M, Salwender H, Wandt H, et al
     Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
     Blood. 2011;117:2121-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. SAWADA Y , Hino R, Hama K, Ohmori S, et al
     The type of skin eruptions is an independent prognostic indicator for adult T-cell leukemia/lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. VAN ROOSBROECK K , Cox L, Tousseyn T, Lahortiga I, et al
     JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. DUNLEAVY K , Bollard CM
     Sobering realities of surviving Hodgkin Lymphoma.
     Blood. 2011;117:1772-3.
     PubMed     Text format     Related articles   
     
     
     
     
146. VEREIDE DT , Sugden B
     Lymphomas differ in their dependence on Epstein-Barr virus.
     Blood. 2011;117:1977-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. DUZKALE H , Schweighofer CD, Coombes KR, Barron LL, et al
     LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts over-all survival in untreated patients.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. MOORE PA , Zhang W, Rainey GJ, Burke S, et al
     Application of Dual-Affinity Re-Targeting (DARTTM) molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. BOGEN B
     Lymphoma invisibility-vaccination-attack?
     Blood. 2011;117:1437-8.
     PubMed     Text format     Related articles   
     
     
     
     
150. RINALDI A , Mian M, Chigrinova E, Arcaini L, et al
     Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
     Blood. 2011;117:1595-604.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. FU J , Qu Z, Yan P, Ishikawa C, et al
     The tumor suppressor gene WWOX links the canonical and noncanonical NF-kappaB pathways in HTLV-I Tax-mediated tumorigenesis.
     Blood. 2011;117:1652-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. CHAKRAVARTY EF , Murray ER, Kelman A, Farmer P, et al
     Pregnancy outcomes after maternal exposure to rituximab.
     Blood. 2011;117:1499-506.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
153. CHRISTOPOULOS P , Pfeifer D, Bartholome K, Follo M, et al
     Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. WEISENBURGER DD , Savage KJ, Harris NL, Gascoyne RD, et al
     Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. KURUVILLA J , Keating A, Crump M
     How I treat relapsed and refractory Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. FELDMAN AL , Dogan A, Smith DI, Law ME, et al
     Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
     Blood. 2011;117:915-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. HISATOMI T , Sueoka-Aragane N, Sato A, Tomimasu R, et al
     NK314 potentiates anti-tumor activity with adult T-cell leukemia-lymphoma cellsby inhibition of dual targets on topoisomerase II{alpha} and DNA-dependent protein kinase.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. PICCALUGA PP , De Falco G, Kustagi M, Gazzola A, et al
     Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. DUTT S , Baker J, Kohrt HE, Kambham N, et al
     CD8+ CD44hi but not CD4+ CD44hi memory T cells mediate potent graft anti-lymphoma activity without GVHD.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. BUGLIO D , Khaskhely NM, Voo KS, Martinez-Valdez H, et al
     HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. FRIEDBERG JW , Vose JM, Kelly JL, Young F, et al
     The combination of bendamustine, bortezomib and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. WRENCH D , Leighton P, Skibola CF, Conde L, et al
     SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. SAVAN R , McFarland AP, Reynolds DA, Feigenbaum L, et al
     A novel role for IL-22R1 as a driver of inflammation.
     Blood. 2011;117:575-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. LANNUTTI BJ , Meadows SA, Herman SE, Kashishian A, et al
     CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.
     Blood. 2011;117:591-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. ALINARI L , Yu B, Christian BA, Yan F, et al
     Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. CARBONE A , Santoro A
     How to diagnose and manage "in situ" lymphoma.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. PHAM LV , Fu L, Tamayo AT, Bueso-Ramos C, et al
     Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-kappaB-inducing kinase while activating both canonical and alternative nuclear factor-kappaB pathways.
     Blood. 2011;117:200-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. GOLDSTEIN MJ , Varghese B, Brody JD, Rajapaksa R, et al
     A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.
     Blood. 2011;117:118-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. TOMIC J , Lichty B, Spaner DE
     Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. BARANISKIN A , Kuhnhenn J, Schlegel U, Chan A, et al
     Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
     Blood. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
171. KOHRT HE , Houot R, Goldstein MJ, Weiskopf K, et al
     CD137 stimulation enhances the anti-lymphoma activity of anti-CD20 antibodies.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. BRETHERICK KL , Bu R, Gascoyne RD, Connors JM, et al
     Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma.
     Blood. 2010;116:6146-7.
     PubMed     Text format     Related articles   
     
     
     
     
173. OLEJNICZAK SH , Blickwedehl J, Belicha-Villanueva A, Bangia N, et al
     Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells.
     Blood. 2010;116:5605-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. TAKEUCHI K , Yokoyama M, Ishizawa S, Terui Y, et al
     Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation.
     Blood. 2010;116:5631-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. ROSSI D , Rasi S, Di Rocco A, Fabbri A, et al
     The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. KIM SJ , Kang HJ, Kim JS, Oh SY, et al
     Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. CLARK RA , Shackelton JB, Watanabe R, Calarese A, et al
     High scatter T cells (THS): a reliable biomarker for malignant T cells in cutaneous T cell lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. BISWAS S , Shi Q, Matise L, Cleveland S, et al
     A role for proapoptotic Bax and Bak in T-cell differentiation and transformation.
     Blood. 2010;116:5237-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. VAN DER POEL CE , Karssemeijer RA, Boross P, van der Linden JA, et al
     Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcgammaRI, in the presence of monomeric IgG.
     Blood. 2010;116:5327-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. VELICHUTINA I , Shaknovich R, Geng H, Johnson NA, et al
     EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.
     Blood. 2010;116:5247-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. CHEVILLARD G , Paquet M, Blank V
     Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. GOLDIN LR , Landgren O, Kristinsson SY, Bjorkholm M, et al
     Infection in infancy and subsequent risk of developing lymphoma in children and young adults.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. JIMA DD , Zhang J, Jacobs C, Richards KL, et al
     Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
     Blood. 2010;116:e118-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. BERGER C , Hoffmann K, Vasquez JG, Mane S, et al
     Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy.
     Blood. 2010;116:4838-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. JACCARD A , Gachard N, Marin B, Rogez S, et al
     Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
186. WESTON VJ , Oldreive CE, Skowronska A, Oscier DG, et al
     The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.
     Blood. 2010;116:4578-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. HUDECEK M , Schmitt TM, Baskar S, Lupo-Stanghellini MT, et al
     The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
     Blood. 2010;116:4532-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. ROUE G , Perez-Galan P, Mozos A, Lopez-Guerra M, et al
     The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by downregulation of the prosurvival ER chaperone BiP/Grp78.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. SUNG CO , Kim SC, Karnan S, Karube K, et al
     Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. PARK SI , Shenoi J, Pagel JM, Hamlin DK, et al
     Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
     Blood. 2010;116:4231-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. TURNER JJ , Morton LM, Linet MS, Clarke CA, et al
     InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
     Blood. 2010;116:e90-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. KELLY KM , Sposto R, Hutchinson R, Massey V, et al
     BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high risk Hodgkin lymphoma: a report from the Children's Oncology Group CCG-59704 clinical trial.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. FOX CP , Haigh TA, Taylor GS, Long HM, et al
     A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.
     Blood. 2010;116:3695-704.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. SANT M , Allemani C, Tereanu C, De Angelis R, et al
     Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
     Blood. 2010;116:3724-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. PHAM LV , Tamayo AT, Li C, Bueso-Ramos C, et al
     An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.
     Blood. 2010;116:3899-906.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. KARJALAINEN K , Jaalouk DE, Bueso-Ramos CE, Zurita AJ, et al
     Targeting neuropilin-1 in human leukemia and lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. LIN Y , Gustafson MP, Bulur PA, Gastineau DA, et al
     Immunosuppressive CD14+HLA-DRlow/neg monocytes in B-cell non-Hodgkin's lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. AUNER HW , Beham-Schmid C, Dillon N, Sabbattini P, et al
     The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress.
     Blood. 2010;116:3445-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. PIEVANI A , Belussi C, Klein C, Rambaldi A, et al
     Enhanced killing of human B lymphoma targets by combined use of cytokine induced killer (CIK) cultures and anti-CD20 antibodies.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. NAVARRETE MA , Heining-Mikesch K, Schuler F, Bertinetti-Lapatki C, et al
     Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
201. CASTELLINO SM , Geiger AM, Mertens AC, Leisenring WM, et al
     Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. GOLAY J , Bologna L, Andre PA, Buchegger F, et al
     Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death.
     Blood. 2010;116:3372-3.
     PubMed     Text format     Related articles   
     
     
     
     
203. CAMPBELL KJ , Bath ML, Turner ML, Vandenberg CJ, et al
     Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
     Blood. 2010;116:3197-207.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. GUPTA P , Goldenberg DM, Rossi EA, Chang CH, et al
     Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias.
     Blood. 2010;116:3258-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. REEDER CB , Ansell SM
     Novel therapeutic agents for B-cell lymphoma: developing rational combinations.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. MANSOOR A , Pittaluga S, Beck PL, Wilson WH, et al
     NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathological features and follow-up in a unique case series.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. SIGAL DS , Miller HJ, Schram ED, Saven A, et al
     Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
     Blood. 2010;116:2884-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
208. HORTON HM , Bernett MJ, Peipp M, Pong E, et al
     Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies.
     Blood. 2010;116:3004-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. MARCUCCI F , Mele A
     Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis and therapeutic opportunities.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. PEREZ-GALAN P , Mora-Jensen H, Weniger MA, Shaffer AL 3rd, et al
     Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. CHEN Y , Zheng T, Lan Q, Foss F, et al
     Cytokine polymorphisms in Th1/Th2 pathway, body mass index, and risk of non-Hodgkin lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. YIN B , Yang-Iott KS, Chao LH, Bassing CH, et al
     Cellular context dependent effects of H2ax and p53 deletion upon the development of thymic lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. JO SH , Schatz JH, Acquaviva J, Singh H, et al
     Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.
     Blood. 2010;116:2759-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. PEREZ-GALAN P , Dreyling M, Wiestner A
     Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
215. KIS LL , Gerasimcik N, Salamon D, Persson EK, et al
     The STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
216. LEAHY MF , Turner JH
     Radio-immunotherapy of indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year, single institution experience of 142 consecutive patients.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
217. COIFFIER B , Thieblemont C, Van Den Neste E, Lepeu G, et al
     Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
     Blood. 2010;116:2040-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. GALPER SL , Yu JB, Mauch PM, Strasser JF, et al
     Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
219. LI J , Maruyama T, Zhang P, Konkel J, et al
     Mutation of inhibitory helix-loop-helix protein Id3 causes {gamma}{delta} T-cell lymphoma in mice.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. DENNISON JB , Shanmugam M, Ayres ML, Qian J, et al
     8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. JIANG X , Lu X, McNamara G, Liu X, et al
     HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. LWIN T , Lin J, Choi YS, Zhang X, et al
     Follicular dendritic cell dependent drug resistance of non-Hodgkin lymphoma involves cell-adhesion-mediated Bim down-regulation through induction of microRNA-181a.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. CRAIG VJ , Muller A
     Response: Gastric MALT lymphoma-derived tumor immunoglobulins are polyreactive and respond to a variety of self and foreign antigens.
     Blood. 2010;116:1819-20.
     PubMed     Text format     Related articles   
     
     
     
     
224. HOOGEBOOM R , Bende RJ, van Noesel CJ
     MALT lymphoma-derived rheumatoid factors are nonpolyreactive high-affinity antibodies.
     Blood. 2010;116:1818-9.
     PubMed     Text format     Related articles   
     
     
     
     
225. HAPPO L , Cragg MS, Phipson B, Haga JM, et al
     Maximal killing of lymphoma cells by DNA-damage inducing therapy requires not only the p53 targets Puma and Noxa but also Bim.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. KHAN FM , Sy S, Louie P, Ugarte-Torres A, et al
     Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa.
     Blood. 2010;116:1803-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. SIVORI S , Falco M, Carlomagno S, Romeo E, et al
     A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.
     Blood. 2010;116:1637-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. BARKER JN , Doubrovina E, Sauter C, Jaroscak JJ, et al
     Successful treatment of Epstein-Barr virus (EBV)-associated post-transplant lymphoma after cord blood transplant using third-party EBV-specific cytotoxic T-lymphocytes.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
229. ENNISHI D , Maeda Y, Niitsu N, Kojima M, et al
     Hepatic toxicity and prognosis in HCV-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. GUECH-ONGEY M , Simard EP, Anderson WF, Engels EA, et al
     AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
231. DEN HOLLANDER J , Rimpi S, Doherty JR, Rudelius M, et al
     Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
     Blood. 2010;116:1498-505.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
232. PFREUNDSCHUH M
     How I treat elderly patients with diffuse large B-cell lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. NAGEL I , Szczepanowski M, Martin-Subero JI, Harder L, et al
     Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
     Blood. 2010;116:1317-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
234. OTT G , Ziepert M, Klapper W, Horn H, et al
     Immunoblastic morphology but not the immunohistochemical GCB/non-GCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. MOSKOWITZ AJ , Yahalom J, Kewalramani T, Maragulia JC, et al
     Pre-transplant functional imaging predicts outcome following autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
236. KASAMA Y , Sekiguchi S, Saito M, Tanaka K, et al
     Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. BALLABIO E , Mitchell T, van Kester MS, Taylor S, et al
     MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
     Blood. 2010;116:1105-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
238. JARDIN F , Jais JP, Molina TJ, Parmentier F, et al
     Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.
     Blood. 2010;116:1092-104.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
239. MATHAI S , Jones GL
     Spurious pleocytosis.
     Blood. 2010;116:678.
     PubMed     Text format     Related articles   
     
     
     
     
240. CAMPBELL JJ , Clark RA, Watanabe R, Kupper TS, et al
     Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.
     Blood. 2010;116:767-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
241. RICKLES RJ , Pierce LT, Giordano TP 3rd, Tam WF, et al
     Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies.
     Blood. 2010;116:593-602.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. THAUNAT O , Morelon E, Defrance T
     Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.
     Blood. 2010;116:515-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. KOCHENDERFER JN , Wilson WH, Janik JE, Dudley ME, et al
     Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically-engineered to recognize CD19.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
244. STANELLE J , Doring C, Hansmann ML, Kuppers R, et al
     Mechanisms of aberrant GATA-3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
245. KUPPERS R
     Genomic imbalances in Hodgkin lymphoma.
     Blood. 2010;116:309-11.
     PubMed     Text format     Related articles   
     
     
     
     
246. LEVY C , Frecha C, Costa C, Rachinel N, et al
     Lentiviral vectors and transduction of human cancer B cells.
     Blood. 2010;116:498-500.
     PubMed     Text format     Related articles   
     
     
     
     
247. STEIDL C , Telenius A, Shah SP, Farinha P, et al
     Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.
     Blood. 2010;116:418-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. SCHMITZ N , Trumper L, Ziepert M, Nickelsen M, et al
     Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
249. BERTRAND KA , Birmann BM, Chang ET, Spiegelman D, et al
     A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
     Blood. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
250. BENITA Y , Cao Z, Giallourakis C, Li C, et al
     Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor.
     Blood. 2010;115:5376-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: